SAN FRANCISCO -- Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Camp Dreamcatcher in Chester County, launched at the height of ‘90s stigma around HIV, has served thousands of children ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...

Priscilla Tsondai, MD, MPH, breaks down top care gaps as opportunities for care improvement.

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...